Free tool
Drugs in development
Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations
Drugs in development
3,685
Not FDA-approved
In Phase 3
1,424
Highest phase reached
Matching your filters
146
146 drugs in development
Names, sponsors and conditions come from the trial records. Click a drug for its trials.
- ADX-2191Phase 31 trial
Aldeyra Therapeutics, Inc. · Primary Vitreoretinal Lymphoma
- ATSN-201Phase 31 trial
Atsena Therapeutics Inc. · X-linked Retinoschisis
- AVT29proposed aflibercept HD biosimilarPhase 31 trial
Alvotech Swiss AG · Diabetic Macular Edema
- CAM-101Elate Ocular, FD hPLPhase 31 trial
Cambium Bio Limited · Dry Eye Disease, Dry Eye, Dry Eyes Chronic
- HLX04-OPhase 31 trial
Shanghai Henlius Biotech · Age Related Macular Degeneration
- Intravitreal RanibizumabPhase 31 trial
Roche (Genentech) · Diabetic Macular Edema
- licaminlimabPhase 31 trial
Oculis · Dry Eye Disease (DED)
- OCU410Phase 31 trial
Ocugen · Dry Age-related Macular Degeneration
- OPC-1085ELPhase 31 trial
Otsuka · Open Angle Glaucoma or Ocular Hypertension
- QL1207HPhase 31 trial
Qilu Pharmaceutical Co., Ltd. · Neovascular Age-Related Macular Degeneration (nAMD)
- RC28-EPhase 31 trial
RemeGen Co., Ltd. · Diabetic Macular Edema (DME), wAMD
- REGN5713BremzalerbartPhase 31 trial
Regeneron · Allergic Conjunctivitis
- REGN5715AtisnolerbartPhase 31 trial
Regeneron · Allergic Conjunctivitis
- RTx-015Phase 31 trial
Ray Therapeutics, Inc. · Retinitis Pigmentosa (RP), Inherited Retinal Diseases
- SJP-0132Phase 31 trial
Senju Pharmaceutical Science & Technology (Beijing) Co., Ltd. · Dry Eye
- VVN001Phase 31 trial
VivaVision Biotech, Inc · Dry Eye
- AL-001lithium salicylate, L-proline cocrystalPhase 23 trials
Beijing Anlong Biopharmaceutical Co., Ltd. · Wet Age-related Macular Degeneration (wAMD), Bipolar I Disorder
- GenSci048Phase 23 trials
Changchun GeneScience Pharmaceutical Co., Ltd. · Uveitis, Systemic Sclerosis Associated Interstitial Lung Disease, Rheumatoid Arthritis Associated Interstitial Lung Disease (RA-ILD)
- QLS-111Phase 23 trials
Qlaris Bio, Inc. · Normal Tension Glaucoma (NTG), Glaucoma, Open-angle Glaucoma (OAG)
- roginolisibIOA-244Phase 23 trials
iOnctura · Myelofibrosis (MF), Non-Squamous Non-Small Cell Lung Cancer (NSCLC), Advanced Non Squamous NSCLC
- TL-925Phase 23 trials
Telios Pharma, Inc. · Allergic Conjunctivitis, Allergic Conjunctivitis of Both Eyes
- 0.25% RCI001RCI001Phase 22 trials
ORA, Inc. · Dry Eye Disease (DED), Dry Eye
- BGE-102Phase 22 trials
BioAge Labs, Inc. · Diabetic Macular Edema (DME), Obesity and Cardiovascular Risk
- BL1107Phase 22 trials
Bausch & Lomb Incorporated · Dry Eye Disease, Glaucoma
- BLU-808Phase 22 trials
Blueprint Medicines Corporation · Chronic Inducible Urticaria, Chronic Spontaneous Urticaria, Allergic Rhinoconjunctivitis
- BRIMOCHOL PF eye dropsCARBACHOL PF eye drops, Brimonidine tartrate eye dropsPhase 22 trials
Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd. · Presbyopia, Recurrent Ovarian Cancer, Folate Receptor-Alpha Positive
- BS01Phase 22 trials
Bionic Sight LLC · Retinitis Pigmentosa, Geographic Atrophy (GA) Secondary to Dry Age-related Macular Degeneration (AMD)
- Intravitreal of UltevursenPhase 22 trials
Laboratoires Thea · Retinitis Pigmentosa (RP), Usher Syndrome Type 2, Deaf Blind
- KHK4951Phase 22 trials
Kyowa Kirin Co., Ltd. · Diabetic Macular Edema (DME), Neovascular Age-Related Macular Degeneration (nAMD)
- LASN01Phase 22 trials
Lassen Therapeutics 1 PTY LTD · Thyroid Eye Disease, Pulmonary Fibrosis, Graves Ophthalmopathy
- NT-101Phase 22 trials
NexThera Co., Ltd. · Wet Age Related Macular Degeneration, Wet AMD
- OpRegenPhase 22 trials
Roche (Genentech) · Age-Related Macular Degeneration, Geographic Atrophy
- PER-001 Intravitreal ImplantPhase 22 trials
Perfuse Therapeutics, Inc. · Diabetic Retinopathy, Open-angle Glaucoma
- PER-001 Intravitreal Implant - ShamPhase 22 trials
Perfuse Therapeutics, Inc. · Diabetic Retinopathy, Open-angle Glaucoma
- rAAV2tYF-GRK1-RPGRPhase 22 trials
Beacon Therapeutics · X-Linked Retinitis Pigmentosa
- TTAX03Phase 22 trials
BioTissue Holdings, Inc · Knee Osteoarthritis, Knee Pain Chronic, Knee Arthritis
- ABBV-6628Phase 21 trial
AbbVie · Geographic Atrophy, Age-Related Macular Degeneration
- ACDN-01Phase 21 trial
Ascidian Therapeutics, Inc · Stargardt Disease, Cone Rod Dystrophy, Juvenile Macular Degeneration
Beacon Therapeutics · X-Linked Retinitis Pigmentosa (XLRP)
- AGN-193408Phase 21 trial
AbbVie · Open-angle Glaucoma, Ocular Hypertension
- AIV007Phase 21 trial
AiViva BioPharma, Inc. · Neovascular (Wet) Age-Related Macular Degeneration
- APL-3007Phase 21 trial
Apellis Pharmaceuticals, Inc. · Geographic Atrophy Secondary to Age-related Macular Degeneration
- AR-17043Phase 21 trial
Alcon Research · Open Angle Glaucoma, Ocular Hypertension
- ASKG712AM712, VIS-101Phase 21 trial
Visara, Inc. · Neovascular Age-related Macular Degeneration
- ASP2767Phase 21 trial
Astellas · Glaucoma
- AVD-104Phase 21 trial
Aviceda Therapeutics, Inc. · Geographic Atrophy of the Macula, Macular Degeneration
- BI 1815368Phase 21 trial
Boehringer Ingelheim · Macular Edema
- BI 3812465Phase 21 trial
Boehringer Ingelheim · Diabetic Macular Edema
- BI 764524Phase 21 trial
Boehringer Ingelheim · Diabetic Retinopathy
- BI 771716Phase 21 trial
Boehringer Ingelheim · Macular Degeneration, Age-related, Geographic Atrophy
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.